| Detected | Trial | Change |
|---|---|---|
| 2026-05-30 | NCT05309616 Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis |
Trial completed |
| 2026-05-14 | NCT06588296 Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis… |
Trial completed |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06398106 | Proactive TDM Versus Standard Use of Biologics in Psoriasis | Psoriasis Vulgaris | Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT06588283 | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe… | Psoriasis | Active, Not Recruiting |
| NCT04527380 | A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis… | Juvenile Psoriatic Arthritis | Active, Not Recruiting |
| NCT06945107 | A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an… | Plaque Psoriasis | Active, Not Recruiting |
| Phase 2 | |||
| NCT04589325 | Ixekizumab Diabetes Intervention Trial (I-DIT) | Type1 Diabetes Mellitus | Active, Not Recruiting |
| Phase 1 | |||
| NCT07200986 | Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy… | Healthy Participants | Active, Not Recruiting |
| Not specified | |||
| NCT07443956 | Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis | Psoriatic Arthritis (PsA) | Recruiting |